Multiple Sclerosis (MS) is an immune-mediated disease that causes the body’s immune system to attack the central nervous system (CNS), the brain, spinal cord and optic nerves make up the CNS. More specifically, the disease attacks myelin, a fatty substance that surrounds and insulates nerve fibers. The immune system sends T-cells, immune response cells,  damaging or destroying the myelin and nerve fiber. When nerve fibers are damaged, messages in the CNS may be changed or stopped. Symptoms of MS varies from person to person depending on severity and sites of attack, but the symptoms are caused by inflammation within the CNS. This is where CBD has potential to help MS sufferers, CBD has shown to have anti-inflammatory and pain-relieving properties. 

 

Multiple Sclerosis CBD Research

​

• CBD used to counteract the development of experimental multiple sclerosis (MS).

• Meta-analysis of cannabis based treatments for neuropathic and multiple sclerosis-related pain. Cannabiniods were found to be effective in treating neuropathic pain in MS.

• Neurological Aspects of Medical Use of Cannabidiol. Study shows evidence of beneficial effects from CBD in Parkinson's disease (PD), Alzheimer's disease (AD), multiple sclerosis (MS) patients.

​

Chronic Pain

​

Chronic pain can come from many sources whether it be illness such as, multiple sclerosis and arthritis, or the result of an injury. Studies have shown CBD to be effective as a therapy to chronic pain and inflammation in mice. CBD, unlike pharmaceutical options for pain relief, doesn’t build a tolerance, making it suitable for a long-term and constant issue.

 

Chronic Pain CBD Research

​

• Role of the cannabinoid system in pain control and therapeutic implications for the management of acute and chronic pain episodes.

• Cannabinoids suppress inflammatory and neuropathic pain by targeting α3 glycine receptors.

• The non-psychoactive cannabis constituent cannabidiol is an orally effective therapeutic agent in rat chronic inflammatory and neuropathic pain.